AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol (August 29, 2003). doi:10.1152/ajplung.00127.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/6/L1286    most recent
00127.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kreiselmeier, N. E.
Right arrow Articles by Kelley, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kreiselmeier, N. E.
Right arrow Articles by Kelley, T. J.
Submitted on April 29, 2003
Accepted on August 22, 2003

Statin-mediated correction of Stat1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells

Norman E. Kreiselmeier1, Nathan C. Kraynack1, Deborah A. Corey1, and Thomas J. Kelley1*

1 Departments of Pediatrics and Pharmacology, Case Western Reserve University and Reainbow Babies and Children's Hosptial, Cleveland, OH, USA

* To whom correspondence should be addressed. E-mail: tjk12{at}po.cwru.edu.

The expression of the inducible form of nitric oxide synthase (NOS2) is reduced in cystic fibrosis (CF) epithelium despite the presence of aggressive inflammation. A potential mechanism for reduced NOS2 expression in CF is diminished signal transducer and activator of transcription-1 (Stat1) activity, possibly due to an increase in expression of protein inhibitor of activated Stat1 (PIAS1). Previous evidence also suggests that NOS2 expression can be negatively regulated by increased activation of the GTPase RhoA, leading to the hypothesis that CF-related increases in PIAS1 expression and altered Stat1 signaling may be mediated by Rho GTPase function. Consistent with this hypothesis, data demonstrate increased expression of RhoA in two models of CF epithelium with a proportional increase in the active GTP-bound RhoA. Mouse embryonic fibroblasts null for p190B Rho GTPase activating protein (RhoGAP -/-) exhibit increased RhoA protein content and activation, similar to what is observed in CF models, and also exhibit CF-like alterations in Stat1 regulation including decreased Stat1 activation, increased PIAS1 protein expression, and reduced NOS2 induction implicating RhoA-mediated signaling in CF-related Stat1 alterations. Inhibition of the Rho GTPase pathway at the level of isoprenoid/cholesterol synthesis with mevastatin reduces PIAS1 expression, increases Stat1 activation, and restores NOS2 expression in models of CF epithelium suggesting that pharmacological inhibition of the isoprenoid synthesis/Rho GTPase pathway may represent a potential avenue for therapeutic intervention for CF.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. E. Manson, D. A. Corey, N. M. White, and T. J. Kelley
cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells
Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L809 - L819.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Perez, A. M. van Heeckeren, D. Nichols, S. Gupta, J. F. Eastman, and P. B. Davis
Peroxisome proliferator-activated receptor-{gamma} in cystic fibrosis lung epithelium
Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L303 - L313.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Perez, A. C. Issler, C. U. Cotton, T. J. Kelley, A. S. Verkman, and P. B. Davis
CFTR inhibition mimics the cystic fibrosis inflammatory profile
Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L383 - L395.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. M. White, D. Jiang, J. D. Burgess, I. R. Bederman, S. F. Previs, and T. J. Kelley
Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis
Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L476 - L486.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
T. E. Machen
Innate immune response in CF airway epithelia: hyperinflammatory?
Am J Physiol Cell Physiol, August 1, 2006; 291(2): C218 - C230.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
Y. Li, W. Wang, W. Parker, and J. P. Clancy
Adenosine Regulation of Cystic Fibrosis Transmembrane Conductance Regulator through Prostenoids in Airway Epithelia
Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 600 - 608.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
J. Y. Lee, H. L. Elmer, K. R. Ross, and T. J. Kelley
Isoprenoid-Mediated Control of SMAD3 Expression in a Cultured Model of Cystic Fibrosis Epithelial Cells
Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 234 - 240.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Zheng, W. Xu, S. Bose, A. K. Banerjee, S. J. Haque, and S. C. Erzurum
Impaired nitric oxide synthase-2 signaling pathway in cystic fibrosis airway epithelium
Am J Physiol Lung Cell Mol Physiol, August 1, 2004; 287(2): L374 - L381.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.